Jeanmonod Patrik 4
4 · Cytek Biosciences, Inc. · Filed Mar 13, 2024
Insider Transaction Report
Form 4
Jeanmonod Patrick
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-11+4,908→ 99,377 total - Tax Payment
Common Stock
2024-03-11$7.22/sh−1,912$13,805→ 97,465 total - Exercise/Conversion
Restricted Stock Units
2024-03-11−4,908→ 44,182 total→ Common Stock (4,908 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents the number of shares withheld by and surrendered to the Issuer on March 11, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
- [F3]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.